Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387651911> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W4387651911 abstract "Background: Lung cancer is still the most lethal malignancy in the world from the report of Cancer Statistics in 2021. Platinum-based chemotherapy combined immunotherapy is the first-line treatment in lung cancer patients. However, the 5-year survival rate always affected by the adverse reaction and drug resistance caused by platinum-based chemotherapy. DNA damage and repair system is one of the important mechanisms which can affect the response to chemotherapy and clinical outcome in lung cancer patients.
 Objective: The objective of this study is to find the relationship between the polymorphisms of DNA repair genes with the prognosis in platinum-based chemotherapy in lung cancer patients.
 Patients and Methods: We performed genotyping in 17 single nucleotide polymorphisms (SNPs) of Excision Repair Cross-Complementation group (ERCC) genes and X-ray Repair Cross-Complementing (XRCC) genes of 345 lung cancer patients by Sequenom MassARRAY. We used Cox proportional hazard models, state and plink to analyze the associations between SNPs and the prognosis of lung cancer patients.
 Results: We found that the ERCC5 rs873601 was associated with the overall survival time in lung cancer patients treat by platinum-based chemotherapy (p=0.031*). We also discovered that the polymorphisms in rs873601 was significantly associated with the prognosis in age more than 55 years, Small Cell Lung Cancer (SCLC) and smoking patients, Long Intergenic Non-protein Coding RNA (PNKY) rs2444933 in age less than 55 years, SCLC, metastasis and stage III/IV/ED patients, Short Tau Inversion Recovery (STIR1) rs3740051 in SCLC and metastasis patients, PNKY rs1869641 in SCLC patients, XRCC5 rs1051685 in non-metastasis patients, respectively.
 Conclusion: The ERCC5 rs873601(G>A) maybe a valuable biomarker for predicting the prognosis in lung cancer patients treated with platinum-based chemotherapy.
 Statements and Declarations: The authors declare that they have no conflict of interest." @default.
- W4387651911 created "2023-10-16" @default.
- W4387651911 creator A5026071162 @default.
- W4387651911 creator A5028732060 @default.
- W4387651911 creator A5034507199 @default.
- W4387651911 creator A5051310867 @default.
- W4387651911 creator A5063346114 @default.
- W4387651911 creator A5069101425 @default.
- W4387651911 creator A5075883718 @default.
- W4387651911 creator A5076859280 @default.
- W4387651911 creator A5091816719 @default.
- W4387651911 date "2023-10-13" @default.
- W4387651911 modified "2023-10-16" @default.
- W4387651911 title "Role of rs873601 Polymorphisms in Prognosis of Lung Cancer Patients Treated with Platinum-Based Chemotherapy" @default.
- W4387651911 doi "https://doi.org/10.20944/preprints202310.0897.v1" @default.
- W4387651911 hasPublicationYear "2023" @default.
- W4387651911 type Work @default.
- W4387651911 citedByCount "0" @default.
- W4387651911 crossrefType "posted-content" @default.
- W4387651911 hasAuthorship W4387651911A5026071162 @default.
- W4387651911 hasAuthorship W4387651911A5028732060 @default.
- W4387651911 hasAuthorship W4387651911A5034507199 @default.
- W4387651911 hasAuthorship W4387651911A5051310867 @default.
- W4387651911 hasAuthorship W4387651911A5063346114 @default.
- W4387651911 hasAuthorship W4387651911A5069101425 @default.
- W4387651911 hasAuthorship W4387651911A5075883718 @default.
- W4387651911 hasAuthorship W4387651911A5076859280 @default.
- W4387651911 hasAuthorship W4387651911A5091816719 @default.
- W4387651911 hasBestOaLocation W43876519111 @default.
- W4387651911 hasConcept C104317684 @default.
- W4387651911 hasConcept C104451858 @default.
- W4387651911 hasConcept C121608353 @default.
- W4387651911 hasConcept C126322002 @default.
- W4387651911 hasConcept C134935766 @default.
- W4387651911 hasConcept C135763542 @default.
- W4387651911 hasConcept C143998085 @default.
- W4387651911 hasConcept C153209595 @default.
- W4387651911 hasConcept C2776256026 @default.
- W4387651911 hasConcept C2776694085 @default.
- W4387651911 hasConcept C2779013556 @default.
- W4387651911 hasConcept C2779309665 @default.
- W4387651911 hasConcept C54355233 @default.
- W4387651911 hasConcept C71924100 @default.
- W4387651911 hasConcept C86803240 @default.
- W4387651911 hasConceptScore W4387651911C104317684 @default.
- W4387651911 hasConceptScore W4387651911C104451858 @default.
- W4387651911 hasConceptScore W4387651911C121608353 @default.
- W4387651911 hasConceptScore W4387651911C126322002 @default.
- W4387651911 hasConceptScore W4387651911C134935766 @default.
- W4387651911 hasConceptScore W4387651911C135763542 @default.
- W4387651911 hasConceptScore W4387651911C143998085 @default.
- W4387651911 hasConceptScore W4387651911C153209595 @default.
- W4387651911 hasConceptScore W4387651911C2776256026 @default.
- W4387651911 hasConceptScore W4387651911C2776694085 @default.
- W4387651911 hasConceptScore W4387651911C2779013556 @default.
- W4387651911 hasConceptScore W4387651911C2779309665 @default.
- W4387651911 hasConceptScore W4387651911C54355233 @default.
- W4387651911 hasConceptScore W4387651911C71924100 @default.
- W4387651911 hasConceptScore W4387651911C86803240 @default.
- W4387651911 hasLocation W43876519111 @default.
- W4387651911 hasOpenAccess W4387651911 @default.
- W4387651911 hasPrimaryLocation W43876519111 @default.
- W4387651911 hasRelatedWork W1763472475 @default.
- W4387651911 hasRelatedWork W1977382129 @default.
- W4387651911 hasRelatedWork W2016004402 @default.
- W4387651911 hasRelatedWork W2027125578 @default.
- W4387651911 hasRelatedWork W2050258759 @default.
- W4387651911 hasRelatedWork W2132336832 @default.
- W4387651911 hasRelatedWork W2163885210 @default.
- W4387651911 hasRelatedWork W2234340700 @default.
- W4387651911 hasRelatedWork W2341950863 @default.
- W4387651911 hasRelatedWork W2950856716 @default.
- W4387651911 isParatext "false" @default.
- W4387651911 isRetracted "false" @default.
- W4387651911 workType "article" @default.